Albumin Market Size - By Product (Human Serum Albumin, Recombinant Albumin, and Bovine Serum Albumin), By Application (Therapeutics, Diagnostics, and Research), By End User (Hospital & Clinics, Pharmaceutical & Biotechnology Industry, and Research Institutes) and By Region: Global & Forecast, 2023-2033

  • 2023-11-27
  • 235
  • Healthcare & Life Sciences

Market Overview

Albumin Market is projected to achieve a value of USD 7.74 Billion in 2023, with a linear behavior in the market growth it is forecasted to achieve a value of USD 11.54 Billion by 2033 with a CAGR of 4.8% during the forecast period 2023-2033.

The most prevalent circulating protein in plasma is called albumin. It is produced by the liver and is essential for controlling blood osmotic pressure. The rise in plasma fractionation facilities, the prevalence of hypoalbuminemia and other illnesses, and the increase in plasma collection are some of the factors propelling the growth of the worldwide albumin market.

Furthermore, there is a global upsurge in research endeavors aimed at ascertaining the efficacy of albumin. Researchers have released a number of papers listing treatment alternatives for various illnesses in a variety of periodicals. Furthermore, advancements made by well-known figures in the upcoming years, the market and a spike in product approvals will offer growth prospects for the worldwide market.

The albumin market is driven by several different things. The market for albumin products is driven by the increased incidence of liver illnesses and the rise in surgical procedures. The pharmaceutical industry's growing usage of albumin for drug formulation and administration further drives market expansion. The use of albumin in cell culture media and vaccine development has increased demand for it due to biotechnology advancements. Additionally, the albumin industry is supported globally by the aging population and the increasing demand for medicines generated from plasma. These combining forces produce a stable market environment in which albumin is still an essential ingredient in the pharmaceutical and medical industries, supporting its ongoing expansion.

In human therapeutics, albumin is greatly needed to replace lost fluids and restore blood volume following operations, major burn injuries, fetal erythroblastosis, hypoproteinemia, and accidents. When compared to serum products of human or animal grade, recombinant albumin has many advantages, including greater homogeneity, purity, and lack of animal content. Moreover, the hydrophobic nature of recombinant human serum products gives them a great ability to transport a variety of ligands. Their need in drug delivery applications has grown as a result. Prominent companies in the worldwide industry are also concentrating on a number of expansion tactics, including collaborations and mergers to expand their product portfolio and create cutting-edge treatments.

The size of the worldwide market increased as a result of the COVID-19 epidemic. The key reason for the market's expansion was the increase in R&D efforts to demonstrate the product's benefits for COVID-19 patients. Furthermore, the COVID-19 pandemic caused major market participants to see a sharp increase in albumin segment revenue. In order to fulfill the rising demand for albumin products, they were concentrating on strategic efforts like partnerships and collaborations as well as increasing their production capabilities.

Market Scope

Report Attributes


Market Size in 2022

USD 6.36 Billion

Market Forecast in 2033

USD 11.54 Billion

CAGR % 2023-2033


Base Year


Historic Data


Forecast Period


Report USP

Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

By Product, By Application, By End user and By Region

Growth Drivers

Albumin is commonly used in the treatment of liver diseases, such as cirrhosis and liver failure. The increasing incidence of liver-related disorders worldwide drives the demand for albumin in medical interventions.

The global aging population is more prone to health issues that may require medical interventions involving albumin. As the elderly population grows, so does the demand for healthcare products, including albumin.

Advances in biotechnology and protein engineering have led to improvements in albumin production methods. These technological advancements can enhance the efficiency and cost-effectiveness of albumin production, positively impacting market growth.

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria

Key Companies

Biorbyt Ltd., Thermo Fisher Scientific Inc., Cyagen Biosciences, ALBUMEDIX, Grifols, S.A., Merck KGaA, Albumin Bioscience, Aspira Chemical, Octapharma AG and others.


Market Dynamics

Market Drivers

Increasing Demand in Medical Applications

The Albumin Market is expanding due to the rise in medical applications. The need for albumin, an essential protein in many therapeutic treatments, is higher because of its many applications in drug delivery systems, expanding plasma volume, and stabilizing formulations in biopharmaceuticals and vaccines. The need for albumin-based therapy in critical care, liver disorders, and surgery is increasing due to the rise in chronic illnesses and the aging population. Moreover, the market's growth is propelled by its capacity to transport drugs and its adaptability to a range of treatments, meeting the growing demand for cutting-edge medical solutions around the globe.

Rising demand for immunoglobulins

The albumin market is influenced by the increasing need for immunoglobulins. Albumin is frequently required for the stabilization and improvement of the therapeutic qualities of immunoglobulins, which are essential drugs used to treat infections, immunodeficiency disorders, and autoimmune illnesses. Albumin is in high demand as a stabilizing agent due to the rising incidence of infectious illnesses and autoimmune disorders, which in turn drives the need for immunoglobulin-based therapy. With the increased emphasis on precision medicine and biopharmaceutical breakthroughs, albumin's role in promoting the stability and efficacy of immunoglobulins becomes increasingly important as the medical landscape changes. This will drive albumin's market expansion and significance in the healthcare industry.

Market restrains

Research and Development Costs

The albumin market is constrained by the high barrier of research and development (R&D) expenses. To assure safety, efficacy, and regulatory compliance, significant investment in research and development is necessary for innovations in albumin-based medicines and formulations. Market expansion is hampered by the high expenses associated with preclinical and clinical trials as well as the requirement for ongoing manufacturing process upgrades. These high R&D costs frequently result in higher product prices, which restricts patients' and healthcare systems' access to albumin-based medicines. It's still difficult to strike a balance between innovation and cost-effectiveness, which prevents albumin from being widely used in a variety of medical applications and limits market growth.

Market By Product Analysis

By Product, the Albumin Market is Categories into Human Serum Albumin, Recombinant Albumin, and Bovine Serum Albumin. The Human Serum Albumin segment accounts for the largest share of around 46% in 2022.

The growing need for HSA-based treatments for a range of conditions, such as burns, shock, and liver failure, is anticipated to propel the HSA subsegment's growth at a CAGR of more than 5% over the course of the projected period.

Market By Application Analysis

By Application, the Albumin Market is Categories into Therapeutics, Diagnostics, and Research. The Therapeutics segment accounts for the largest share of around 37% in 2022.

The increasing number of product approvals from national regulatory bodies, the demand for albumin in R&D operations, which results in the development of novel goods, and the rise in the use of these products for therapeutic purposes are all factors contributing to the segment's expansion.

Market By End User Analysis

By End user, the Albumin Market is Categories into Hospital & Clinics, Pharmaceutical & Biotechnology Industry, and Research Institutes. The Hospital & Clinics segment accounts for the largest share of around 45% in 2022. The market is predicted to expand significantly throughout the forecast period. This dominance is due to the advent of albumin-based medicinal regimens and their application in hospital settings.

Market Regional Analysis

North America dominate the Albumin Market with the highest revenue generating market with share of more than 41%. The primary reasons for this rise are the growing number of elderly people, the escalating incidence of chronic illnesses, and the growing use of albumin-based treatments. In this regional market, the United States is the leading player, followed by Canada and Mexico.

Europe is projected to become the second-largest region in this market, showing steady growth in the long term. The aging population, the increasing burden of chronic diseases, and the rising need for albumin-based treatments are the main drivers of growth in this area. With a substantial market share, Germany dominates the albumin market in Europe. Other major producers include the UK, France, and Italy.

Asia Pacific is expected to be the fastest-growing market for Albumin during the forecast period. The increasing incidence of chronic illnesses, the growing senior population, and the developing healthcare system are all blamed for this extraordinary growth trajectory. The biggest albumin market in the Asia-Pacific area is undoubtedly China, which is followed by South Korea, Japan, and India.

Competitive Analysis

The Albumin Market is dominated by a few large companies, such as Cargill, Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Grain Processing Corporation, BENEO GmbH, The Scoular Company, SÜDSTÄRKE GmbH, Sudzucker AG, Bunge Limited, Associated British Foods plc, Emsland Group, AGRANA Beteiligungs-AG, Tate & Lyle PLC, Roquette Frères and other.

There are some of the key trends that are shaping the competitive landscape of the Albumin Market.

June 2023, Sartorius AG (ALBUMEDIX) and Cell and Gene treatment Catapult (CGT Catapult) worked together to explore the use of albumin-based solutions from the company for advanced treatment applications, such as the production of viral vectors.

May 2023, AlbuminBound, paclitaxel protein-bound particles for injectable solution are a new offering from American Regent, Inc. as an alternative to Abraxane.

Research Report Following Segments:

By Product

·         Human Serum Albumin

·         Recombinant Albumin

·         Bovine Serum Albumin

By Application

·         Therapeutics

·         Diagnostics

·         Research

By End user

·         Hospital & Clinics

·         Pharmaceutical & Biotechnology Industry

·         Research Institutes

1.      Global Albumin Market Introduction and Market Overview

1.1.   Objectives of the Study

1.2.   Global Albumin Market Scope and Market Estimation

1.2.1.      Global Albumin Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2033)

1.2.2.      Global Albumin Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2033

1.3.   Market Segmentation

1.3.1.      Component of Global Albumin Market

1.3.2.      Technology of Global Albumin Market

1.3.3.      End-user of Global Albumin Market

1.3.4.      Region of Global Albumin Market

2.      Executive Summary

2.1.   Global Albumin Market Industry Trends under COVID-19 Outbreak

2.1.1.      Global COVID-19 Status Overview

2.1.2.      Influence of COVID-19 Outbreak on Global Albumin Market Industry Development

2.2.   Market Dynamics

2.2.1.      Drivers

2.2.2.      Limitations

2.2.3.      Opportunities

2.2.4.      Impact Analysis of Drivers and Restraints

2.3.   Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.   Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.   Porter’s Five Forces Analysis

2.5.1.      Bargaining Power of Suppliers

2.5.2.      Bargaining Power of Buyers

2.5.3.      Threat of Substitutes

2.5.4.      Threat of New Entrants

2.5.5.      Competitive Rivalry

2.6.   Value Chain / Ecosystem Analysis

2.7.   Russia-Ukraine War Impacts Analysis

2.8.   Economic Downturn Analysis

2.9.     Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Albumin Market Estimates & Historical Trend Analysis (2019 - 2022)

4.      Global Albumin Market Estimates & Forecast Trend Analysis, by PRODUCT

4.1.   Global Albumin Market Revenue (US$ Mn) Estimates and Forecasts, by PRODUCT, 2019 to 2033

4.1.1.      Human Serum Albumin

4.1.2.      Recombinant Albumin

4.1.3.      Bovine Serum Albumin

5.      Global Albumin Market Estimates & Forecast Trend Analysis, by Application

5.1.   Global Albumin Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2033

5.1.1.      Therapeutics

5.1.2.      Diagnostics

5.1.3.      Research

6.      Global Albumin Market Estimates & Forecast Trend Analysis, by End-user

6.1.   Global Albumin Market Revenue (US$ Mn) Estimates and Forecasts, by End-user, 2019 to 2033

6.1.1.      Hospital & Clinics

6.1.2.      Pharmaceutical & Biotechnology Industry

6.1.3.      Research Institutes

7.      Global Albumin Market Estimates & Forecast Trend Analysis, by Region

7.1.   Global Albumin Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2033

7.1.1.      North America

7.1.2.      Europe

7.1.3.      Asia Pacific

7.1.4.      Middle East & Africa

7.1.5.      South America

8.      North America Albumin Market: Estimates & Forecast Trend Analysis

8.1.   North America Albumin Market Assessments & Key Findings

8.1.1.      North America Albumin Market Introduction

8.1.2.      North America Albumin Market Size Estimates and Forecast (US$ Million) (2019 – 2033)  By PRODUCT  By Application  By End-user  By Country   The U.S.   Canada   Mexico

9.      Europe Albumin Market: Estimates & Forecast Trend Analysis

9.1.   Europe Albumin Market Assessments & Key Findings

9.1.1.      Europe Albumin Market Introduction

9.1.2.      Europe Albumin Market Size Estimates and Forecast (US$ Million) (2019 – 2033)  By PRODUCT  By Application  By End-user      By Country   Germany   U.K.   France   Italy   Spain   Russia   Rest of Europe

10.  Asia Pacific Albumin Market: Estimates & Forecast Trend Analysis

10.1. Asia Pacific Market Assessments & Key Findings

10.1.1.  Asia Pacific Albumin Market Introduction

10.1.2.  Asia Pacific Albumin Market Size Estimates and Forecast (US$ Million) (2019 – 2033)  By PRODUCT  By Application  By End-user  By Country              China              Japan              India              Australia              South Korea              ASEAN              Rest of Asia Pacific

11.  Middle East & Africa Albumin Market: Estimates & Forecast Trend Analysis

11.1. Middle East & Africa Market Assessments & Key Findings

11.1.1.  Middle East & Africa Albumin Market Introduction

11.1.2.  Middle East & Africa Albumin Market Size Estimates and Forecast (US$ Million) (2019 – 2033)  By PRODUCT  By Application  By End-user  By Country                 U.A.E.                 Saudi Arabia                 Egypt                 South Africa                 Rest of Middle East & Africa

12.  South America Albumin Market: Estimates & Forecast Trend Analysis

12.1. South America Market Assessments & Key Findings

12.1.1.  South America Albumin Market Introduction

12.1.2.  South America Albumin Market Size Estimates and Forecast (US$ Million) (2019 – 2033)  By PRODUCT  By Application  By End-user  By Country              Brazil              Argentina              Colombia              Rest of South America

13.  Competition Landscape

13.1. Global Albumin Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

13.2. Global Albumin Market Competition White Space Analysis, By End-user

13.3. Global Albumin Market Competition Heat Map Analysis, By End-user

13.4. Global Albumin Market Concentration & Company Market Shares (%) Analysis, 2022

14.  Company Profiles

14.1.                    Biorbyt Ltd..

14.1.1.  Company Overview & Key Stats

14.1.2.  Financial Performance & KPIs

14.1.3.  Product Portfolio

14.1.4.  Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

14.2.     Thermo Fisher Scientific Inc.

14.3.     Cyagen Biosciences

14.4.     ALBUMEDIX

14.5.     Grifols, S.A.

14.6.     Merck KGaA

14.7.     Albumin Bioscience

14.8.     Aspira Chemical

14.9.     Octapharma AG 

14.10. others

15.  Research Methodology

15.1. External Transportations / Databases

15.2. Internal Proprietary Database

15.3. Primary Research

15.4. Secondary Research

15.5. Assumptions

15.6. Limitations

15.7. Report FAQs

16.  Research Findings & Conclusion


Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process

We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).


The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.

Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Albumin Market in 2022?

Albumin Market was valued at USD 6.36 Billion in 2022.

What is the growth rate for the Albumin Market?

Albumin Market size will increase at approximate CAGR of 4.8% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Albumin Market are Biorbyt Ltd., Thermo Fisher Scientific Inc., Cyagen Biosciences, ALBUMEDIX, Grifols, S.A., Merck KGaA, Albumin Bioscience, Aspira Chemical, Octapharma AG and others.

Which region dominates the Albumin Market?

North America dominates the market with an active share of 41%.


Select a license type that suits your business needs

Single User Access

US $3950

Only Three Thousand Nine Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4950

Only Four Thousand Nine Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5950

Only Five Thousand Nine Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI